By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BG Medicine today announced it has entered into a secure loan facility for up to $15 million.

The loan facility is with GE Capital's Healthcare Financial Services and Comerica Bank. An initial $10 million was funded to the Waltham, Mass.-based company on Feb. 10. Subject to certain revenue milestones and other conditions being met, BG Medicine may draw an additional $5 million term loan on or before Feb. 10, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.